GDRX
Goodrx Holdings Inc
3.30$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 56.7% | 54.9% | 50.4% | 50.9% | 46.3% | 47.5% | 41.7% | 41.8% | 42.7% | 45.8% | 62.7% | 68.3% | |
| 46.5% | 42.3% | 36.7% | 35.6% | 31.3% | 32.3% | 23.2% | 21.3% | 20.6% | 18.6% | 11.7% | 12.6% | |
| 46.5% | 42.3% | 36.7% | 35.6% | 31.3% | 32.3% | 23.2% | 21.3% | 20.6% | 18.6% | 11.7% | 12.6% | |
| 7.9% | 10.1% | 11.1% | 12.8% | 11.8% | 11.6% | 13.3% | 15.3% | 16.4% | 18.2% | 12.1% | 53.7% | |
| 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 24.1% | 25.9% | 28.3% | 27.8% | 30.3% | 29.6% | 32.6% | 32.0% | 31.8% | 30.6% | 21.3% | 18.4% | |
| 10.6% | 9.8% | 11.1% | 11.4% | 12.8% | 12.7% | 15.4% | 15.5% | 15.5% | 14.5% | 10.0% | 8.5% | |
| 48.4% | 52.0% | 56.6% | 54.6% | 48.6% | 47.8% | 49.5% | 51.2% | 54.7% | 56.1% | 69.2% | 72.4% | |
| 6.9% | 7.7% | 8.0% | 6.9% | 8.4% | 8.9% | 8.0% | 9.9% | 13.7% | 17.5% | 42.5% | 49.4% | |
| 0.6% | 0.9% | 0.8% | 0.8% | 0.7% | 0.8% | 0.8% | 0.7% | 0.7% | 0.7% | 0.5% | 0.4% | |
| 1.9% | 2.3% | 2.3% | 1.1% | 0.9% | 1.0% | 1.2% | 1.9% | 2.2% | 1.4% | 0.7% | 0.4% | |
| 38.0% | 40.8% | 44.5% | 43.8% | 36.0% | 35.1% | 37.5% | 36.8% | 36.5% | 34.4% | 23.9% | 20.6% | |
| 51.6% | 48.0% | 43.4% | 45.4% | 51.4% | 52.2% | 50.5% | 48.8% | 45.3% | 43.9% | 30.8% | 27.6% | |
| -83.8% | -91.7% | -100.3% | -98.4% | -106.9% | -103.8% | -110.4% | -107.5% | -106.8% | -100.5% | -69.7% | -59.8% | |
| 24.2% | 25.2% | 26.8% | 26.1% | 28.7% | 27.6% | 29.3% | 27.1% | 26.2% | 24.3% | 16.9% | 14.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.